Tesaro’s Ovarian Cancer Therapy Zejula Moves One Step Closer to EU Approval
News
The European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Tesaro‘s Zejula (niraparib) as a maintenance therapy for recurrent platinum-sensitive ovarian ... Read more